Share Price:

APNASPENAspen Pharmacare Hldgs143640 (0.00%)

Aspen is in a closed period from 1st July 2026 until the publication of the annual results on the JSE SENS platform on the 2nd September 2026.

Our Stories

Our Stories

Aspen EME partners with EMAS to advance education on menopause-related care

Earlier this year, Aspen EME collaborated with the European Menopause and Andropause Society (EMAS) to deliver a series of educational webinars for healthcare professionals focused on Genitourinary Syndrome of Menopause (GSM). Held in March, April and June 2026, the sessions provided a valuable platform for expert-led learning and scientific exchange on an important, yet often overlooked, aspect of women’s health.

Read More
Our Stories

Continuous Learning: Building Capability, Confidence and Community at Aspen By Kurt Drieselmann, Group Executive: Legal

If there is one lesson my career has reinforced, it is that knowledge only creates value when it is refreshed, challenged and shared. In a business as dynamic and global as Aspen, we cannot afford to stand still. The legal environment evolves, business priorities shift, technology advances and expectations rise. To serve the business well, we must keep learning, questioning and sharing what we know.

Read More

Media Enquiries

Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com

Share on social

Follow on social

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: